Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe

被引:119
作者
Viviani, Maria Anna
Cogliati, Massimo
Esposto, Maria Carmela
Lemmer, Karin
Tintelnot, Kathrin
Valiente, Maria Francisca Colom
Swinne, Danielle
Velegraki, Aristea
Velho, Rosa
机构
[1] Univ Milan, Ist Igiene & Med Prevent, Lab Micol Med, IRCCS,Osped Maggiore, I-20133 Milan, Italy
[2] Robert Koch Inst, Consultant Lab Cryptococcus Neoformans, D-1000 Berlin, Germany
[3] Univ Miguel Hernandez, Dept Microbiol, Alicante, Spain
[4] Sci Inst Publ Hlth, Mycol Sect, Brussels, Belgium
[5] Univ Athens, Sch Med, Dept Microbiol, Reference Mycol Lab, GR-11527 Athens, Greece
[6] Hosp Univ Coimbra, Serv Patol Clin, Coimbra, Portugal
关键词
Cryptococcus neoformans; cryptococcosis; molecular epidemiology; genotype; serotype; mating type;
D O I
10.1111/j.1567-1364.2006.00081.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
During a European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis in Europe (from July 1997 to December 1999) 655 cases were reported from 17 countries; 565 of the completed questionnaires were evaluable. Cryptococcosis was associated with HIV infection in 77% of cases (range 57.5-94%). Assessment of the laboratory data highlighted the lack of defined standard procedures for the diagnosis of cryptococcosis: the antigen test was not usually used for screening, the disease was mainly recognised when meningitis occurred (65% of patients) and, with the exception of a few cases, the extent of the infection was not investigated. Cryptococcus neoformans was the etiological agent in all of the cases except for six caused by C. gattii and four by other Cryptococcus species. A total of 311 C. neoformans strains were serotyped by Crypto Check latex agglutination, genotyped by PCR-fingerprinting using the (GACA)(4) oligonucleotide as a single primer, and their mating type was determined by PCR of the STE20 alleles. Serotype A was the most represented (51% of the isolates), followed by serotype D (30%) and serotype AD (19%). PCR-fingerprinting analysis significantly increased the percentage of hybrid strains to 30%, as 6% of the serotype A and 28% of the serotype D isolates were of the VN3 or VN4 hybrid genotype. In addition, the mating type determinations revealed the MATa serotype A allele in one haploid strain and 28 hybrids, and hybrid isolates with a single mating type (four A alpha and two D alpha) were also identified. This is the first prospective survey to be carried out in Europe which has attempted to investigate the epidemiology of cryptococcosis and the population structure of C. neoformans, and the results obtained thus far show the widespread involvement of AD hybrid strains in C. neoformans infections.
引用
收藏
页码:614 / 619
页数:6
相关论文
共 20 条
[1]
Barnett J.A., 1990, YEASTS CHARACTERISTI, DOI DOI 10.1046/J.1525-1470.2001.1862020A.X
[2]
Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans [J].
Boekhout, T ;
Theelen, B ;
Diaz, M ;
Fell, JW ;
Hop, WCJ ;
Abeln, ECA ;
Dromer, F ;
Meyer, W .
MICROBIOLOGY-UK, 2001, 147 :891-907
[3]
Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand [J].
Chen, S ;
Sorrell, T ;
Nimmo, G ;
Speed, B ;
Currie, B ;
Ellis, D ;
Marriott, D ;
Pfeiffer, T ;
Parr, D ;
Byth, K .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :499-508
[4]
Origin of Cryptococcus neoformans var. neoformans diploid strains [J].
Cogliati, M ;
Esposito, MC ;
Clarke, DL ;
Wickes, BL ;
Viviani, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :3889-3894
[5]
Cogliati M, 2000, J MYCOL MED, V10, P171
[6]
Epidemiology of HIV-associated cryptococcosis in France (1985-2001):: comparison of the pre- and post-HAART eras [J].
Dromer, F ;
Mathoulin-Pélissier, S ;
Fontanet, A ;
Ronin, O ;
Dupont, B ;
Lortholary, O .
AIDS, 2004, 18 (03) :555-562
[7]
Epidemiology of cryptococcosis in France: A 9-year survey (1985-1993) [J].
Dromer, F ;
Mathoulin, S ;
Dupont, B ;
Laporte, A ;
Chardon, H ;
Greze, H ;
Hayette, MP ;
Chabasse, D ;
Martin, M ;
Pulik, M ;
Hautefort, B ;
LePennec, MP ;
Larfouilloux, J ;
Faller, JP ;
Barale, T ;
BougesMichel, C ;
Delzanig, G ;
Couprie, B ;
Bougnoux, ME ;
Masure, O ;
Lefort, C ;
Duhamel, C ;
Bidault, C ;
Zaegel, M ;
Allard, C ;
Laurens, E ;
Dormont, J ;
Beytout, J ;
Mollo, JL ;
Boussougant, Y ;
Cordier, F ;
Bretagne, S ;
Gaillard, JP ;
Portier, H ;
Grise, G ;
Leblanc, A ;
Bouchard, I ;
Nauciel, C ;
Lebeau, B ;
Bouree, P ;
Lagarde, A ;
Vincent, J ;
DesaillyChanson, MA ;
Eloy, O ;
Grillot, ML ;
Gosset, X ;
Capbern, P ;
Darde, ML ;
Lemercier, Y ;
Piens, MA .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (01) :82-90
[8]
Cryptococcus neoformans var. grubii:: Separate varietal status for Cryptococcus neoformans serotype A isolates [J].
Franzot, SP ;
Salkin, IF ;
Casadevall, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) :838-840
[9]
Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons [J].
Hajjeh, RA ;
Conn, LA ;
Stephens, DS ;
Baughman, W ;
Hamill, R ;
Graviss, E ;
Pappas, PG ;
Thomas, C ;
Reingold, A ;
Rothrock, G ;
Hutwagner, LC ;
Schuchat, A ;
Brandt, ME ;
Pinner, RW .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (02) :449-454
[10]
Genetics of Cryptococcus neoformans [J].
Hull, CM ;
Heitman, J .
ANNUAL REVIEW OF GENETICS, 2002, 36 :557-615